Non Alcoholic Fatty Liver Disease | OMICS International | Endocrinology And Metabolic Syndrome

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Non Alcoholic Fatty Liver Disease

NAFLD is recognized as risk factor per se for Coronary Artery Disease (CAD). Subjects with fatty liver have an increased risk to develop CAD, and are accompanied by an increase in inflammatory markers, C-reactive protein and also proatherogenic factors. Studies evaluating endothelial function showed that subjects with Non alcoholic fatty liver disease (NAFLD) had decreased endothelium-dependent vasodilatation correlated with the severity of liver disease In these subjects a strong association was seen with high triglycerides, suggesting that hypertriglyceridemia might be a crucial link between hepatic steatosis, insulin resistance, and endothelial dysfunction. Obesity, Non Alcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD): Dhastagir sultan Sheriff* and Manopriya T
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on April, 2021